Successful treatment of severe immune checkpoint inhibitor associated autoimmune hepatitis with basiliximab: a case report

• Maiah Zarrabi,
• Camille Hamilton,
• Samuel W. French,
• Noah Federman,
• Theodore S. Nowicki,
• Theodore S. Nowicki

Affiliations

Maiah Zarrabi

Department of Pediatrics, University of California, Los Angeles Mattel Children’s Hospital, Los Angeles, CA, United States

Camille Hamilton

Division of Pediatric Hematology Oncology, Department of Pediatrics, University of California, Los Angeles Mattel Children’s Hospital, Los Angeles, CA, United States

Samuel W. French

Department of Pathology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States

Noah Federman

Division of Pediatric Hematology Oncology, Department of Pediatrics, University of California, Los Angeles Mattel Children’s Hospital, Los Angeles, CA, United States

Theodore S. Nowicki

Division of Pediatric Hematology Oncology, Department of Pediatrics, University of California, Los Angeles Mattel Children’s Hospital, Los Angeles, CA, United States

Theodore S. Nowicki

Department of Microbiology, Immunology, and Molecular Genetics (MIMG), University of California, Los Angeles, Los Angeles, CA, United States